Advertisement
Organisation › Details
Avacta (Group)
Avacta’s principal focus is on its proprietary Affimer® technology which is a novel engineered alternative to antibodies that has wide application in Life Sciences for diagnostics, therapeutics and general research and development. Antibodies dominate markets worth in excess of $100bn despite their shortcomings. Affimer technology has been designed to address many of these negative performance issues, principally; the time taken to generate new antibodies, the reliance on an animal’s immune response, poor specificity in many cases, and batch to batch variability. Affimer technology is based on a small protein that can be quickly generated to bind with high specificity and affinity to a wide range of protein targets. Avacta has a pre-clinical biotech development programme with an in-house focus on immuno-oncology as well as partnered development programmes. Avacta is commercialising non-therapeutic Affimer reagents through licensing to developers of life sciences research tools and diagnostics. *
Start | 2007-11-14 existent | |
Industry | analytical instrument | |
Industry 2 | diagnostics (medical/biological) | |
Region | Leeds, West Yorkshire | |
Country | United Kingdom (GB) | |
Street | Ash Way, Unit 20 Thorp Arch Estate | |
City | LS23 7FA Wetherby | |
Tel | +44-1904-21-7070 | |
Address record changed: 2024-05-09 | ||
Basic data | Employees | n. a. |
* Document for »About Section«: Selexis S.A.. (6/20/19). "Press Release: Avacta and Selexis Partner to Develop Cell Line for Clinical Manufacturing". Cambridge & Geneva. | ||
Record changed: 2024-05-09 |
Advertisement
More documents for Avacta (Group)
To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com
Advertisement
» top